This series will explore the history of Alzheimer’s, living with the disease day-to-day, the highs and lows of developing drugs to treat it and what can be done to improve the situation for caregivers ...
Alzheimer's drug development has a long history of overpromising and underdelivering, with most candidates ultimately failing to show meaningful clinical benefit. Drug companies often manipulate data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results